ArticleJournal of Alzheimer's disease : JAD2022

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials.

Poul F Høilund-Carlsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.